Despite the significant disease burden, Myalgic encephalomyelitis (ME), previously known as chronic fatigue syndrome (CFS), lacks effective diagnostics and therapeutics. Emily Taylor, President and CEO of Solve M.E., explains why dedicated research for Infection-Associated Chronic Conditions and Illnesses (IACCIs) such as ME/CFS is vitally needed.
Researchers from the Wellcome Sanger Institute, University College London (UCL), and Imperial College London have revealed insights into why some people remain unscathed despite exposure to SARS-CoV-2, the virus responsible for COVID-19.
Long COVID can be debilitating, and thus, further research and support for those living with the condition are urgently needed. Yanto Evans and Michael Natt from Long Covid Support discuss the unmet medical needs and strategies to improve understanding and care for Long COVID patients.
We spoke to Dr Charles Shepherd about the impact of myalgic encephalomyelitis/chronic fatigue syndrome and why more needs to be done to address gaps in care and research.
Zisis Kozlakidis and Caboux Elodie from the International Agency for Research on Cancer discuss how the COVID-19 pandemic accelerated the adoption of changes in public health interventions and patient care.
The UK Health Security Agency (UKHSA) has secured a groundbreaking UK-based vaccine deal, strengthening the nation's readiness for potential influenzas pandemics.
The COVID-19 pandemic triggered a temporary increase in children residing with grandparents and extended family members, underscoring the significance of multi-generational living.
A study in Hypertension highlights an association between COVID-19 and persistent high blood pressure, among specific demographics and people with preexisting health conditions.
The Long COVID lessons learned beyond the COVID-19 pandemic are detailed here by leading Professors working on the University College London STIMULATE-ICP programme.
CEO of ViewMind Inc, Mark Edwards, discusses the cognitive effects of Long COVID, aiming to understand the science behind brain fog and other COVID symptoms.
Long-term COVID-19 effects have been decreased from anywhere between 50 and 80% for those who have been vaccinated when compared to unvaccinated people.
